theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Dermatology

Vitiligo   

Questions discussed in this category


How do you manage new-onset vitiligo in a patient on immune checkpoint inhibitors?
Do you hold ICI, prescribe steroids, or refer to dermatology, and does your approach vary between curative, adjuvant, or metastatic settings?
3 Answers available

What prescription or over-the-counter therapies have you found effective for helping vitiligo patients cover active areas?
3 Answers available
2557514256


Papers discussed in this category


The New England journal of medicine, 2022 Oct 20
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.

JAAD case reports, 2024 Nov 26
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma.

MedComm, 2025 Mar 04
Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment.

Related Topics in Dermatology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.